https://doi.org/10.4081/ejh.2019.2981
Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
Accepted: 8 February 2019
HTML: 17
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Deleted in Liver Cancer (DLC) proteins belong to the family of RhoGAPs and are believed to operate as negative regulators of the Rho family of small GTPases. So far, the role of the first identified member from the DLC family, DLC1, was established as a tumor suppressor in hepatocellular carcinoma. The function of its close family relative, DLC2 is unequivocal. In the present study we attempted to determine whether the loss of DLC2 is a common feature of hepatocellular carcinoma tissue. We examined two types of hepatocellular carcinoma- typical and fibrolamellar one. Our analysis revealed that DLC2 protein is not diminished in cancer tissue when compared to non-cancerous liver specimens. What is more, we observed DLC2 to be more abundantly expressed in cancer tissue, particularly in tumors with the inflammation background. In addition, we found that DLC2 gene status was diploid in virtually all tumor samples examined. Our results indicate that DLC2 is not diminished in hepatocellular carcinoma cells. It appears that members of the DLC family, although structurally highly related, may function differently in cancer cells.
Supporting Agencies
Polish State Committee for Scientific Research, Medical University of Warsaw, PolandHow to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- D. Cabibi, A.G. Giannone, C. Mascarella, C. Guarnotta, M. Castiglia, G. Pantuso, E. Fiorentino, Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus , European Journal of Histochemistry: Vol. 58 No. 1 (2014)
- J. Suchánková, S. Legartová, P. Sehnalová, S. Kozubek, S. Valente, D. Labella, A. Mai, C. Eckerich, F.O. Fackelmayer, D.V. Sorokin, E. Bartova, PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage , European Journal of Histochemistry: Vol. 58 No. 2 (2014)
- Maria Augusta Karas Zella, Ana Paula Martins Sebastião, Luiz Martins Collaço, Daniel Cury Ogata, Guilherme Cecchetti, Ivan José Paredes Bartolomei, Ana Maria Waaga-Gasser, Carmen Australia Paredes Marcondes Ribas, Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma , European Journal of Histochemistry: Vol. 64 No. 4 (2020)
- Eva Jennische, Stefan Lange, Ragnar Hultborn, Dark-field microscopy enhance visibility of CD31 endothelial staining , European Journal of Histochemistry: Vol. 64 No. 3 (2020)
- Y. Asara, J. A. Marchal, P. Bandiera, V. Mazzarello, L. G. Delogu, M. A. Sotgiu, A. Montella, R. Madeddu, Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells , European Journal of Histochemistry: Vol. 56 No. 1 (2012)
- V. V. Philimonenko, J. Janácek, P. Hozák, LR White is preferable to Unicryl for immunogold detection of fixationsensitive nuclear antigens , European Journal of Histochemistry: Vol. 46 No. 4 (2002)
- C. Loreto, L. E. Almeida, M.R. Migliore, M. Caltabiano, R. Leonardi, TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study , European Journal of Histochemistry: Vol. 54 No. 3 (2010)
- S. Nemolato, T. Cabras, M.U. Fanari, F. Cau, D. Fanni, C. Gerosa, B. Manconi, I. Messana, M. Castagnola, G. Faa, Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract , European Journal of Histochemistry: Vol. 54 No. 4 (2010)
- E. Lacunza, V. Ferretti, C. Barbeito, A. Segal-Eiras, M. V. Croce, Immunohistochemical evidence of Muc1 expression during rat embryonic development , European Journal of Histochemistry: Vol. 54 No. 4 (2010)
- L. Pilloni, P. Bianco, E. DiFelice, S. Cabras, M.E. Castellanos, L. Atzori, C. Ferreli, P. Mulas, S. Nemolato, G. Faa, The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions , European Journal of Histochemistry: Vol. 55 No. 2 (2011)
<< < 13 14 15 16 17 18 19 > >>
You may also start an advanced similarity search for this article.
